Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.9900
-0.5400 (-35.29%)
At close: Jun 12, 2026, 4:00 PM EDT
0.9699
-0.0201 (-2.03%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Gelteq Market Cap
Gelteq has a market cap or net worth of $10.6 million as of June 12, 2026. Its market cap has decreased by -33.12% in one year.
Market Cap
10.60M
Enterprise Value
13.14M
1-Year Change
-33.12%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on October 29, 2024, Gelteq's market cap has decreased from $37.75M to $10.60M, a decrease of -71.91%. That is a compound annual growth rate of -54.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 10.60M | 23.75% |
| Dec 31, 2025 | 8.57M | -60.87% |
| Dec 31, 2024 | 21.90M | -42.00% |
| Oct 29, 2024 | 37.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioXcel Therapeutics | 34.27M |
| China Pharma Holdings | 31.08M |
| Optimi Health | 26.46M |
| Rockwell Medical | 24.57M |
| Aytu BioPharma | 23.51M |
| TherapeuticsMD | 21.07M |
| Apimeds Pharmaceuticals US | 18.86M |
| China SXT Pharmaceuticals | 14.60M |